Case study · Biotech · Life Sciences
From rudimentary website to
consistent qualified pipeline
Key Results:
- Generating 2–3 qualified meetings per month.
- +150% Website traffic increase after redesign.
- 20+ New LinkedIn connections per month.
- 15k+ Qualified leads in the database.
The Challenge
Strong science. Zero commercial infrastructure.
Invitrolize has developed a breakthrough in vitro respiratory toxicology model, ALIsens® . But their commercial reality told a different story: no CRM, no structured outreach, and a website that wasn't converting visitors into leads. Every lead came through personal contacts, and that wasn't scalable.
The approach
Six workstreams. One integrated strategy.
Rather than launching outreach before the foundations were right, we built the commercial infrastructure first — then activated each channel in sequence.
- ICP and buyer persona definition
- Full website redesign — conversion focused
- LinkedIn ads and organic campaigns
- Automated email and LinkedIn outreach
- 15,000+ qualified leads. Built from scratch.
- Conference outreach strategy
The Results
Twelve months in. Still growing.
Qualified meetings per month
Consistent flow of meetings with real ICPs and Buyer Personas generated entirely through structured outreach, not personal network.
Website traffic increase
Driven by the new conversion-focused website, LinkedIn content campaigns and improved organic search presence across key regulatory science terms.
New LinkedIn connections
Qualified connections with decision-makers across pharma, cosmetics, chemicals and CROs. Building a network asset that compounds over time.